New International Report on Health Care : U.S. Suicide Rate Highest Among Wealthy Nations


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Organization for Economic Cooperation and Development (OECD)
U.S. Outspends Other High-Income Countries on Health Care But Has Lowest Life Expectancy

The United States spends substantially more than any other wealthy nation on health care, yet it has a lower life expectancy and a higher suicide rate than its peer nations, according to a new Commonwealth Fund report.

The report, U.S. Health Care from a Global Perspective, 2019 : Higher Spending, Worse Outcomes, compares the United States to 10 other high-income nations in the Organization for Economic Cooperation and Development (OECD : Australia, Canada, France, Germany, the Netherlands, New Zealand, Norway, Sweden, Switzerland, and the United Kingdom. Commonwealth Fund researchers examined U.S. health care spending, outcomes, risk factors, and quality relative to these other countries. They also compared U.S. performance to the average of all 36 OECD member nations.

Among the key findings:

The U.S. has the highest suicide rate of any wealthy nation. Suicides account for 14 deaths per 100,000 people in the U.S. This is double the suicide rate of the United Kingdom. Potential factors that contribute to the high U.S. suicide rate include a high burden of mental illness, a lack of mental health screening, inadequate investment in social services, and the inability of many people to pay for mental health treatment. In recent years, Americans have experienced an uptick in “deaths of despair,” which include suicides and deaths related to substance use and drug overdoses.


The U.S. spends more on health care than any other high-income country. In 2018, the U.S. spent 16.9 percent of its gross domestic product (GDP) on health care – almost double what the average OECD country spent. In contrast, New Zealand and Australia devoted only 9 percent of GDP to health care. U.S. health spending now totals more than $10,000 per person. Private insurance costs (premiums and employer-sponsored coverage) drive much of this spending in the U.S. The amount of public health care spending in the U.S., meanwhile, is similar to many other countries.

The U.S. has the lowest life expectancy. Despite spending more on health care, Americans have the lowest life expectancy – 78.6 years, a full two years lower than the average for other wealthy nations. People in the U.S. die five years sooner, on average than people in Switzerland, which has the highest life expectancy in the OECD.
Americans visit the doctor less frequently but use expensive technologies and procedures more often. The average American has only four physician visits per year – approximately half as many as the Dutch and Australians. But the highest rates of MRI scans and hip replacements for older adults are in the U.S.


The U.S. does better than most other high-income nations when it comes to preventive measures such as flu vaccinations and breast cancer screenings. Sixty-eight percent of adults over age 65 in the U.S. had a flu vaccine in 2016, compared to 44 percent in other OECD countries. The U.S. also excels in providing breast cancer screening for women ages 50 to 69, with 80 percent getting appropriate screenings, compared to 61 percent in peer nations, on average. The U.S. fiveyear survival rate for breast cancer is highest among high-income countries — more than five percentage points above the OECD average. However, the U.S. ranks last among the 11 countries on five-year survival for cervical cancer, possibly reflecting lower emphasis on screening for this disease.
The U.S. has one of the highest rates of hospitalizations for preventable conditions and the highest rate of avoidable deaths. U.S. hospitalizations related to diabetes and hypertension, considered preventable with sufficient access to primary care, are approximately 50 percent higher than the OECD average. Only Germany has a higher rate of preventable hospitalizations for the two conditions. While preventable deaths overall have been falling in each of the 11 nations since 2000, the U.S. continues to have the highest rates of premature deaths from causes such as diabetes, hypertensive diseases, and certain cancers — all considered preventable with timely access to primary care and good chronic disease management.


Implications


The authors recommend some steps to reverse these trends:

Reduce health care costs. Lowering health care prices is likely to have the greatest impact on U.S. health spending. Other nations take steps to contain costs through budgeting practices and value-based pricing of medical technologies.
Invest in primary care. Making access to affordable care more readily available and strengthening primary care could make a big difference for the people who need the most care.
Promote incentives to use effective care and cut down on wasteful care. Recent studies suggest that as much as $935 billion in annual U.S. health care spending goes to ineffective care that provides minimal benefit. The U.S. can learn from other countries and assess what tests and treatments are truly necessary.

Tags : #Wealth #Report #Suicide #Health #Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Clinical Interventions in Chronic Hepatitis B and C: Antiviral Efficacy, Liver Fibrosis Scoring, and Monitoring August 11, 2026
Common Health Mistakes Indians Should Avoid: A Practical Guide to Everyday WellnessAugust 11, 2026
How to Build a Healthy Lifestyle After 40: A Practical Guide for Indian AdultsAugust 11, 2026
Milk Microbiome Could Hold New Clues to Lifelong Health, Experts SayAugust 10, 2026
Globally Renowned Dermatologist and Sesderma Founder Professor Dr. Gabriel Serrano to Visit India to Showcase Cutting-Edge Derma-Tech for Indian Skincare at Scientific Symposiums Hosted by Iberia PharmaceuticalsAugust 10, 2026
Sharda Hospital Celebrates World Breastfeeding Week with a Week-Long Awareness ProgrammeAugust 10, 2026
Swinburne University of Technology Opens Applications for Master of Engineering ScienceAugust 10, 2026
GLP-1 Receptor Agonists: A New Era in Weight Loss TreatmentAugust 10, 2026
Immunotherapy vs. Chemotherapy: Understanding the Mechanisms of Precision OncologyAugust 10, 2026
Mitigating Tech-Induced Ailments: Managing Screen Time, Sedentary Lifestyles, and Dry Eye SyndromeAugust 10, 2026
The Blueprint of Validation: Navigating Medical AI’s "Reckoning Year"August 10, 2026
The Future of Smart Hospitals: Redefining Healthcare Delivery in India August 10, 2026
Healthcare Data Security in India: Risks, Threats, and Best Practices for a Digital-First Health EcosystemAugust 10, 2026
The Science of Resilience: Psychological Strategies for Modern StressAugust 08, 2026
The Science of Fasting: 2026 Research on Autophagy and LongevityAugust 08, 2026
Early Markers of Insulin Resistance: Moving Beyond Fasting Blood SugarAugust 08, 2026
Healthcare Management Challenges in India: What Hospital Leaders Must Address NowAugust 08, 2026
Importance of Patient Safety: Why Every Hospital in India Must Prioritize ItAugust 08, 2026
Decoding Fatty Liver Disease: Symptoms, Reversibility, and the MASLD/NAFLD SpectrumAugust 07, 2026
Heart-Healthy Dietary Patterns: Translating Clinical Nutrition Guidelines into Daily MealsAugust 07, 2026